STOCK TITAN

William Lewis to sell 3,009 INSM (NASDAQ: INSM) shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

William Lewis filed a notice of proposed sale under Rule 144 to sell 3,009 shares of common stock through Merrill Lynch in Washington, DC. The shares are listed on NASDAQ, and the approximate sale date stated is February 3, 2026.

The shares to be sold were acquired on February 1, 2026 via stock plan activity from the issuer. Over the prior three months, William Lewis reported several other common stock sales, including blocks of 19,215 and 10,699 shares, with disclosed gross proceeds for each transaction.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the INSM Form 144 filing by William Lewis disclose?

The filing discloses that William Lewis plans to sell 3,009 shares of common stock under Rule 144. The shares will be sold through Merrill Lynch on NASDAQ, with an approximate sale date of February 3, 2026 and stated aggregate market value information.

How many INSM shares is William Lewis proposing to sell in this notice?

William Lewis is proposing to sell 3,009 shares of common stock. These shares are to be sold through Merrill Lynch, with the securities listed on NASDAQ, and the notice specifies an approximate sale date of February 3, 2026 for the planned transaction.

How and when did William Lewis acquire the INSM shares being sold?

The 3,009 shares to be sold were acquired on February 1, 2026 through stock plan activity from the issuer. The filing classifies the acquisition as common stock, notes the issuer as the source, and indicates the same date as the date of payment with non-cash consideration marked as not applicable.

What prior INSM stock sales has William Lewis reported in the last three months?

The notice lists multiple prior common stock sales over the last three months, including blocks of 10,699, 19,215, 4,096, and other amounts. Each transaction entry includes the sale date, number of shares sold, and reported gross proceeds for that specific sale.

Which broker and exchange are involved in William Lewis’s planned INSM share sale?

The planned sale of 3,009 common shares is to be executed through Merrill Lynch, located at 1800 K Street NW, Suite 800, Washington, DC 20006. The filing identifies NASDAQ as the securities exchange where the common stock is traded and intended to be sold.

What representation does the seller make about non-public information in this INSM Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. The form also warns that intentional misstatements or omissions can constitute federal criminal violations.
Insmed Inc

NASDAQ:INSM

View INSM Stock Overview

INSM Rankings

INSM Latest News

INSM Latest SEC Filings

INSM Stock Data

31.32B
214.05M
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER